about
Beta-endorphin 1-31 biotransformation and cAMP modulation in inflammationNeuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake.Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 CellsEph/Ephrin signaling in injury and inflammation.The role of δ-opioid receptors in learning and memory underlying the development of addiction.EPHA4-FC TREATMENT REDUCES ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY BY INHIBITING VASCULAR PERMEABILITY.The Evolution of Fangs, Venom, and Mimicry Systems in Blenny Fishes.Detection of anti-TNFalpha activity in canine hyperimmune serum using a TNFalpha inhibition assay.Binge-like sucrose consumption reduces the dendritic length and complexity of principal neurons in the adolescent rat basolateral amygdala.Biotransformation of beta-endorphin and possible therapeutic implications.The efficacy of Dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation.Inhibitory effects of dynorphin 3-14 on the lipopolysaccharide-induced toll-like receptor 4 signalling pathway.Role of complement anaphylatoxin receptors in a mouse model of acute burn-induced pain.Burn Pain: A Systematic and Critical Review of Epidemiology, Pathophysiology, and Treatment.The antihypertensive drug pindolol attenuates long-term but not short-term binge-like ethanol consumption in mice.Toxins as tools: Fingerprinting neuronal pharmacology.Dynorphin A 1-17 biotransformation in inflamed tissue, serum and trypsin solution analysed by liquid chromatography-tandem mass spectrometry.Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administrationTRPV1 activation alters the function of Aδ and C fiber sensory neurons that innervate bone
P50
Q35117580-CDA6FC18-7EE0-4499-86C9-1C111CD38801Q35974049-61F1BDBE-15F5-4455-A302-7205580C9352Q35982624-9A1BA54E-CC42-451E-A1A4-113E6E057C01Q38047589-BA8191C7-6928-4759-99A5-4D324AD6B9D8Q38196926-8FCF0E52-6C50-45CA-9B33-B4615E32BFA2Q38803263-AF916E1C-F842-4C1F-8FEE-61D9D0779D4FQ38933840-A67EFEEF-DB39-49CB-AFF9-8CE10C9702DCQ39830108-66BB4D5D-8F37-49B1-A90D-A6AA63479D9BQ41432979-8FC5B667-3E8F-4F59-9D9B-6AD15D06DADBQ41964452-A096232B-58F5-4534-BACC-AF43F40AB06FQ44342364-B0526269-2C6A-4ED5-8010-941594577770Q47327850-8C403967-B3A5-4B38-A5F9-05C5DD4F3600Q47560412-1B11118F-7F98-416A-9EB4-5058A1F8CB3BQ47785613-998EFCAF-237C-4482-8D83-60B5B6B654D1Q48690330-D2830681-CE3F-40D6-8378-A61866625238Q50096964-563982C0-075A-4E5D-BE1D-212C4CF242CBQ52301530-2720C567-1293-4B62-9587-1CDAB5BE9267Q63916955-B011AA17-1230-4AE0-A957-142F84066F9FQ92764535-A2488A46-B785-42FE-B043-FA6B903A0955
P50
description
researcher ORCID ID = 0000-0002-3641-2774
@en
name
Michael Morgan
@ast
Michael Morgan
@en
Michael Morgan
@es
Michael Morgan
@nl
type
label
Michael Morgan
@ast
Michael Morgan
@en
Michael Morgan
@es
Michael Morgan
@nl
prefLabel
Michael Morgan
@ast
Michael Morgan
@en
Michael Morgan
@es
Michael Morgan
@nl
P1153
57054753100
P31
P496
0000-0002-3641-2774